Letero

Letero

letrozole

Manufacturer:

Hetero Labs

Distributor:

Camber
Concise Prescribing Info
Contents
Letrozole
Indications/Uses
Adjuvant treatment of postmenopausal women w/ hormone receptor +ve early breast cancer. Extended adjuvant treatment of early breast cancer in postmenopausal women who received 5 yr of adjuvant tamoxifen therapy. 1st-line treatment of postmenopausal women w/ hormone receptor +ve or unknown, locally advanced or metastatic breast cancer. Advanced breast cancer in postmenopausal women w/ disease progression following antiestrogen therapy.
Dosage/Direction for Use
2.5 mg tab once daily. Hepatic impairment 2.5 mg every other day.
Administration
May be taken with or without food.
Special Precautions
Monitor bone mineral density; serum cholesterol. Hepatic impairment. May impair ability to drive or operate machinery. Lactation.
Adverse Reactions
Bone effects; hypercholesterolemia.
ATC Classification
L02BG04 - letrozole ; Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.
Presentation/Packing
Form
Letero FC tab 2.5 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in